It is not possible to determine how many times a bottle can be used, as each dose of this medication needs to be adjusted according to the condition. Semaglutide is indicated for glycemic control in adults with type 2 diabetes. The starting dose of simelglutide is 0.25 mg once weekly and after 4 weeks, it should be increased to 0.5 mg; after treatment with 0.5 mg once weekly for at least 4 weeks, the dose may be increased to 1 mg once weekly in order to further improve the level of glycemic control. Doses greater than 1 mg weekly are not recommended. Semaglutide should not be used in patients with a prior or family history of medullary thyroid cancer and in patients with multiple endocrine neoplasia syndrome type 2. Adverse reactions such as hypoglycemia, nausea, and diarrhea may occur. It is contraindicated in people who are allergic to the product, in pregnant and lactating women, and its use in children under 18 years of age is currently unknown. Simeglutide belongs to the prescription drugs, the specific dosage should follow the doctor’s instructions, not self-medication, in order to avoid adverse reactions.